1. Kim, Hye Rim, Hong, Jin-Kyung, Kim, Yongsub, Choi, Jeong-Yun. 2024. HEBP2 affects sensitivity to cisplatin and BCNU but not to paclitaxel in MDA-MB-231 breast cancer cells. In Toxicological research, 40, 561-569. doi:10.1007/s43188-024-00249-w. https://pubmed.ncbi.nlm.nih.gov/39345749/
2. Currie, David, Wong, Nicole, Zane, Isabelle, Huntley, Derek, Montano, Ximena. 2024. A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients. In Cancers, 16, . doi:10.3390/cancers16040722. https://pubmed.ncbi.nlm.nih.gov/38398114/
3. Yang, BiKang, Dai, Miao. 2024. High-dimensional deconstruction of ovarian cancer at single-cell precision reveals HEBP2 that reshape the TIME and drive carboplatin resistance. In Translational oncology, 44, 101917. doi:10.1016/j.tranon.2024.101917. https://pubmed.ncbi.nlm.nih.gov/38554571/
4. Shen, Jing, Xiao, Chenxu, Qiao, Xiwen, Pan, Julong, Feng, Yu. 2024. A diagnostic model based on bioinformatics and machine learning to differentiate bipolar disorder from schizophrenia and major depressive disorder. In Schizophrenia (Heidelberg, Germany), 10, 16. doi:10.1038/s41537-023-00417-1. https://pubmed.ncbi.nlm.nih.gov/38355593/
5. Muniz, Maria Malane Magalhães, Fonseca, Larissa Fernanda Simielli, Magalhães, Ana Fabrícia Braga, Chardulo, Artur Loyola, de Albuquerque, Lucia Galvão. 2020. Use of gene expression profile to identify potentially relevant transcripts to myofibrillar fragmentation index trait. In Functional & integrative genomics, 20, 609-619. doi:10.1007/s10142-020-00738-9. https://pubmed.ncbi.nlm.nih.gov/32285226/